A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2014
At a glance
- Drugs Lacosamide (Primary) ; Fosphenytoin
- Indications Seizures
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2012 Actual patient number is 11 according to ClinicalTrials.gov.
- 23 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.